Jay R. Venkatesan - 26 Nov 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director
Signature
/s/ Jay Venkatesan
Issuer symbol
ELTX
Transactions as of
26 Nov 2024
Net transactions value
+$500
Form type
4
Filing time
29 Nov 2024, 07:39:46 UTC
Previous filing
25 Nov 2024
Next filing
13 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Exercise of in-the-money or at-the-money derivative security $500 +50,000 +39% $0.0100 179,581 26 Nov 2024 Direct F1
holding ELTX Common Stock 953 26 Nov 2024 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Warrant to Purchase Common Stock Exercise of in-the-money or at-the-money derivative security $0 -50,000 -100% $0.000000 0 26 Nov 2024 Common Stock 50,000 $0.0100 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 26, 2024, the Reporting Person exercised a pre-funded warrant to purchase an aggregate of 50,000 shares of the Issuer's common stock.
F2 The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.
F3 N/A